                         SEQUENCE LISTING

<110>  Oncorus, Inc.
       Greenberg, Kenneth P.
       Finer, Mitchell H.
 
<120>  ONCOLYTIC VIRAL VECTORS AND USES THEREOF

<130>  ONCR-001/01WO

<150>  US 62/287,619
<151>  2016-01-27

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Mutated gB glycoprotein


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Position of gB substitution mutation, D to N

<400>  1

Val Tyr Pro Tyr Xaa Glu Phe Val Leu 
1               5                   


<210>  2
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Mutated gB glycoprotein


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Position of gB substitution mutation, A to T

<400>  2

Lys Leu Asn Pro Asn Xaa Ile Ala Ser 
1               5                   


<210>  3
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Mutated gB glycoprotein


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Position of gB substitution mutation, S to N

<400>  3

Ile Thr Thr Val Xaa Thr Phe Ile Asp 
1               5                   


<210>  4
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Mutated gB glycoprotein


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Position of gH substitution mutation, N to K

<400>  4

Val Asp Thr Asp Xaa Thr Gln Gln Gln 
1               5                   


<210>  5
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Mutated gB glycoprotein


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Position of gH substitution mutation, A to V

<400>  5

Val Pro Ser Thr Xaa Leu Leu Leu Phe 
1               5                   


